Close Menu

NEW YORK (GenomeWeb) – Somalogic said today it has entered a collaboration with Janssen Research & Development to analyze clinical samples using its SomaScan proteomics platform.

Under the agreement, Somalogic will measure roughly 5,000 proteins in at least 15,000 clinical samples to discover and validate protein markers to help predict, diagnose, monitor, and treat disease including rheumatoid arthritis, inflammatory bowel disease, lupus, and cardiovascular and metabolic conditions.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Gene editing could be an issue competitive sports need to address soon, four researchers from Arizona State University write at Slate.

A genetic alteration appears to increase heart failure risk among people of African descent, according to the Washington Post.

In his look back at the past decade, BuzzFeed News' Peter Aldhous writes that direct-to-consumer genetic testing has led to "Facebook for genes."

In Nature this week: genetic "clock" that can predict the lifespans of vertebrates, new assembler called wtdbg2, and more.